Delivery Order SPE2DB20D3103-SPE2DB22FP8G3
- Not listed
- This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The $1,297.41 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024. The contract has an ultimate completion date of November 1, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of ATROPINE 1 MG/ML VIALML to the Defense Logistics Agency (DLA). The contract, valued at $1,886.51, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 19, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $14,051.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,138,140 units of Atropine 1 mg/ml vials, with a performance period extending through May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Atropine 8 mg/20 ml vials to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and healthcare solutions. The contract has a ceiling value of $1,100.08 and a completion date of April 29, 2024. The contract type is a Delivery Order with a Firm...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is a delivery order (SPE2DX15D1120|SPE2DX25FCHLL) with a ceiling value of $1,578.78 for the delivery of Atropine 8 mg/20 ml vials. The contract is not set aside and is a firm fixed price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This $1,567.17 federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Atropine 8 mg/20 ml vials. The contract, valued at $1,334.43, is a delivery order awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,679.08, is a delivery order for 4,567,467,615 units of 1 mg/mL Atropine vials. It is a firm fixed-price contract with a period of performance through March 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,295.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atropine 1 mg/ml vials, a critical medical product used in various healthcare settings. The award is a firm-fixed-price delivery order contract, with a completion date of June 17, 2024. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $1,236.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATROPINE 1 MG/10 ML SYRINGE 10ML, a critical medical commodity, with a performance period ending on June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP8G3Delivery Order
This federal contract award is for the delivery of Atropine 1 mg/ml vial to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under their $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract has a ceiling value of $7,317.10 and a completion date of September 12, 2022. This delivery order is part of Amerisourcebergen's broader role as a key supplier of pharmaceutical products and medical supplies to various federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. The contract was awarded on an unrestricted, full and open competition basis, without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/9/22 |